301 related articles for article (PubMed ID: 23155443)
1. Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.
Kaufmann U; Diedrichs-Möhring M; Wildner G
PLoS One; 2012; 7(11):e49008. PubMed ID: 23155443
[TBL] [Abstract][Full Text] [Related]
2. The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models.
Diedrichs-Möhring M; Kaufmann U; Wildner G
Prog Retin Eye Res; 2018 Jul; 65():107-126. PubMed ID: 29496590
[TBL] [Abstract][Full Text] [Related]
3. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis.
Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G
Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581
[TBL] [Abstract][Full Text] [Related]
4. Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signatures.
von Toerne C; Sieg C; Kaufmann U; Diedrichs-Möhring M; Nelson PJ; Wildner G
Mol Immunol; 2010; 48(1-3):272-80. PubMed ID: 20727594
[TBL] [Abstract][Full Text] [Related]
5. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
6. What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells.
Wildner G; Kaufmann U
Autoimmun Rev; 2013 Sep; 12(11):1070-5. PubMed ID: 23685277
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type I IFN.
Okada AA; Keino H; Suzuki J; Sakai J; Usui M; Mizuguchi J
Int Immunol; 1998 Dec; 10(12):1917-22. PubMed ID: 9885913
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
Yu CR; Kim SH; Mahdi RM; Egwuagu CE
J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
[TBL] [Abstract][Full Text] [Related]
9. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis.
Jia X; Hu M; Wang C; Wang C; Zhang F; Han Q; Zhao R; Huang Q; Xu H; Yuan H; Ren H
Mol Vis; 2011; 17():1493-507. PubMed ID: 21686325
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
[TBL] [Abstract][Full Text] [Related]
11. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells.
Caspi R
Immunol Res; 2008; 42(1-3):41-50. PubMed ID: 18629448
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
15. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
[TBL] [Abstract][Full Text] [Related]
16. TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations.
Lyu C; Bing SJ; Wandu WS; Xu B; Shi G; Hinshaw SJ; Lobera M; Caspi RR; Lu L; Yang J; Gery I
Eur J Immunol; 2018 Nov; 48(11):1810-1816. PubMed ID: 30218573
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
Agarwal RK; Horai R; Viley AM; Silver PB; Grajewski RS; Su SB; Yazdani AT; Zhu W; Kronenberg M; Murray PJ; Rutschman RL; Chan CC; Caspi RR
J Immunol; 2008 Apr; 180(8):5423-9. PubMed ID: 18390724
[TBL] [Abstract][Full Text] [Related]
18. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
[TBL] [Abstract][Full Text] [Related]
20. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
